These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 7296288

  • 21. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C, Slevin JT.
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [Abstract] [Full Text] [Related]

  • 22. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y, Pélaprat D, Montagne MN, Scherman D, Rostène W.
    Brain Res; 1990 Mar 05; 510(2):203-10. PubMed ID: 1970504
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat.
    Fage D, Guerin B, Feuerstein C, Demenge P, Scatton B.
    Brain Res; 1984 Sep 24; 310(2):379-83. PubMed ID: 6488029
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway.
    Ariano MA.
    Brain Res; 1988 Mar 08; 443(1-2):204-14. PubMed ID: 2965958
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS, Fine A, Robertson HA.
    Brain Res; 1991 Jan 25; 539(2):304-11. PubMed ID: 1675908
    [Abstract] [Full Text] [Related]

  • 38. Postsynaptic striatal dopamine agonist or antagonist actions of (+) or (-) 3-PPP and modification after receptor deafferentation.
    Oberlander C, Boissier JR.
    J Pharmacol; 1983 Jan 25; 14(4):401-4. PubMed ID: 6423905
    [Abstract] [Full Text] [Related]

  • 39. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
    Pich EM, Benfenati F, Farabegoli C, Fuxe K, Meller E, Aronsson M, Goldstein M, Agnati LF.
    Brain Res; 1987 Dec 01; 435(1-2):147-52. PubMed ID: 2962698
    [Abstract] [Full Text] [Related]

  • 40. Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions.
    Eghbali M, Santoro C, Paredes W, Gardner EL, Zukin RS.
    Proc Natl Acad Sci U S A; 1987 Sep 01; 84(18):6582-6. PubMed ID: 2819882
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.